Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,419 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rosuvastatin reduces neointima formation in a rat model of balloon injury.
Preusch MR, Vanakaris A, Bea F, Ieronimakis N, Shimizu T, Konstandin M, Morris-Rosenfeld S, Albrecht C, Kranzhöfer A, Katus HA, Blessing E, Kranzhöfer R. Preusch MR, et al. Among authors: shimizu t. Eur J Med Res. 2010 Nov 25;15(11):461-7. doi: 10.1186/2047-783x-15-11-461. Eur J Med Res. 2010. PMID: 21159570 Free PMC article.
ASO Visual Abstract: Larger Tumor Size and Elevated Serum Chromogranin A Levels Predict Metastatic Disease on DOTATATE Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors.
Labora A, Shimizu T, Moore A, Premji A, Armstrong WR, Chen KY, Link J, Chan CS, Allen-Aurbach MS, Donahue TR. Labora A, et al. Among authors: shimizu t. Ann Surg Oncol. 2024 Nov 18. doi: 10.1245/s10434-024-15740-9. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39557724 No abstract available.
Initial adjustments in the dosage and rest period of gemcitabine plus cisplatin therapy for patients with incurable biliary tract cancer based on baseline estimated glomerular filtration rate (eGFR) values may be crucial for treatment outcomes and the preservation of renal function.
Masumoto T, Yamai T, Nakamura K, Kamizono K, Sugioka H, Miyazaki T, Kiyota R, Maegawa Y, Shimizu T, Kawai S, Tawara S, Inoue T, Yakushijin T. Masumoto T, et al. Among authors: shimizu t. J Gastrointest Oncol. 2024 Oct 31;15(5):2277-2285. doi: 10.21037/jgo-24-330. Epub 2024 Oct 24. J Gastrointest Oncol. 2024. PMID: 39554560 Free PMC article.
Cellular communication network factor 3 contributes to the pathological process of rheumatoid arthritis through promoting cell senescence and osteoclastogenesis in the joint.
Tokuhiro T, Matsumae G, Endo T, Ogawa Y, Ogawa T, Liyile C, Nishida Y, Alhasan H, Kobayashi H, Ebata T, Shimizu T, Takahashi D, Onodera T, Kadoya K, Terkawi MA, Iwasaki N. Tokuhiro T, et al. Among authors: shimizu t. J Autoimmun. 2024 Nov 15;149:103334. doi: 10.1016/j.jaut.2024.103334. Online ahead of print. J Autoimmun. 2024. PMID: 39549484
First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti-PD-1 antibody budigalimab in patients with advanced solid tumors.
Shimizu T, Powderly J, Abdul Razak A, LoRusso P, Miller KD, Kao S, Kongpachith S, Tribouley C, Graham M, Stoll B, Patel M, Sahtout M, Blaney M, Leibman R, Golan T, Tolcher A. Shimizu T, et al. Front Oncol. 2024 Oct 29;14:1376551. doi: 10.3389/fonc.2024.1376551. eCollection 2024. Front Oncol. 2024. PMID: 39534099 Free PMC article.
10,419 results
You have reached the last available page of results. Please see the User Guide for more information.